Ashish C. Shrestha
Adelaide, SA 5011, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Influenza Epidemiology and Vaccine Effectiveness Following Funded Influenza Vaccine in Queensland, Australia, 2022.
Journal: Influenza and other respiratory viruses
Published: April 26, 2024
Safety Profile of a Multi-Antigenic DNA Vaccine Against Hepatitis C Virus.
Journal: Vaccines
Published: January 10, 2020
Cytolytic Perforin as an Adjuvant to Enhance the Immunogenicity of DNA Vaccines.
Journal: Vaccines
Published: March 08, 2019
Single-Dose Vaccination with a Hepatotropic Adeno-associated Virus Efficiently Localizes T Cell Immunity in the Liver with the Potential To Confer Rapid Protection against Hepatitis C Virus.
Journal: Journal of virology
Published: February 22, 2019
Toward DNA-Based T-Cell Mediated Vaccines to Target HIV-1 and Hepatitis C Virus: Approaches to Elicit Localized Immunity for Protection.
Journal: Frontiers in cellular and infection microbiology
Published: November 23, 2018
A Comparative Study of Assay Performance of Commercial Hepatitis E Virus Enzyme-Linked Immunosorbent Assay Kits in Australian Blood Donor Samples.
Journal: Journal of blood transfusion
Published: August 18, 2016
Hepatitis E virus seroepidemiology: a post-earthquake study among blood donors in Nepal.
Journal: BMC infectious diseases
Published: August 10, 2016
Hepatitis E virus infections in travellers: assessing the threat to the Australian blood supply.
Journal: Blood transfusion = Trasfusione del sangue
Published: March 15, 2016
Hepatitis E virus: do locally acquired infections in Australia necessitate laboratory testing in acute hepatitis patients with no overseas travel history?
Journal: Pathology
Published: January 07, 2015
Hepatitis E virus and implications for blood supply safety, Australia.
Journal: Emerging infectious diseases
Published: October 24, 2014
Showing 1-12 of 12
Last Updated: 09/26/2026